Pacific Edge, PPO MultiPlan Sign Deal Covering Bladder Cancer Dx | GenomeWeb

NEW YORK (GenomeWeb) – Pacific Edge recently announced a contract with preferred provider organization MultiPlan covering Pacific Edge's Cxbladder test.

The deal provides coverage of the bladder cancer test to MultiPlan's members and includes Pacific Edge's participation in the MultiPlan, PHCS, and PHCS Savility Networks. About 900,000 providers participate in MultiPlan's networks and about 68 million patients have access to the networks, Pacific Edge said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.